Iron deposits in multiple sclerosis and Alzheimer's disease brains - PubMed (original) (raw)
Iron deposits in multiple sclerosis and Alzheimer's disease brains
S M LeVine. Brain Res. 1997.
Abstract
Iron may contribute to the pathogenesis of neurological diseases by promoting oxidative damage. The localization of iron in multiple sclerosis (MS) and Alzheimer's disease (AD) brains was investigated to further the understanding of its pathogenic role in these disease states. Earlier studies, utilizing a standard Perls' stain, yielded conflicting reports regarding the distribution of iron deposits in MS brains, and a previous study on AD brains utilized a diaminobenzidine (DAB) enhanced version of this stain. In the present study, a modified version of the DAB-enhanced stain was used; it utilizes sodium borohydride, proteinase K, Triton X-100 and xylenes to increase the accessibility of tissue iron to histochemical reagents. This modified method can reveal iron deposits that are missed by the Perls' or DAB-enhanced Perls' stains. In addition to its normal deposition in oligodendrocytes and myelin, iron was detected in reactive microglia, ameboid microglia and macrophages in MS brains. In AD brains, three types of plaques were stained: dense core, clear core and amorphous plaques. Punctate staining was also observed in neurons in the corticies of AD brains. The structure accounting for punctate labeling may be damaged mitochondria, lipofuscin or amyloid deposits. Dense core plaques, clear plaques and punctate labeling were not detected in the previous AD study which utilized only the DAB-enhanced Perls' stain. The labeling of these additional structures illustrates the benefit of the modified method. In summary, the localization of iron deposition in MS and AD brains indicates potential sites where iron could promote oxidative damage in these disease states.
Similar articles
- Histological co-localization of iron in Abeta plaques of PS/APP transgenic mice.
Falangola MF, Lee SP, Nixon RA, Duff K, Helpern JA. Falangola MF, et al. Neurochem Res. 2005 Feb;30(2):201-5. doi: 10.1007/s11064-004-2442-x. Neurochem Res. 2005. PMID: 15895823 Free PMC article. - [Histochemical detection of hepatic iron. A comparative study of four stains].
Turlin B, Loreal O, Moirand R, Brissot P, Deugnier Y, Ramee MP. Turlin B, et al. Ann Pathol. 1992;12(6):371-3. Ann Pathol. 1992. PMID: 1284107 French. - Morphologically distinct types of amyloid plaques point the way to a better understanding of Alzheimer's disease pathogenesis.
D'Andrea MR, Nagele RG. D'Andrea MR, et al. Biotech Histochem. 2010 Apr;85(2):133-47. doi: 10.3109/10520290903389445. Biotech Histochem. 2010. PMID: 20121465 - Pathogenic implications of iron accumulation in multiple sclerosis.
Williams R, Buchheit CL, Berman NE, LeVine SM. Williams R, et al. J Neurochem. 2012 Jan;120(1):7-25. doi: 10.1111/j.1471-4159.2011.07536.x. Epub 2011 Nov 11. J Neurochem. 2012. PMID: 22004421 Free PMC article. Review. - Potential Involvement of Peroxisome in Multiple Sclerosis and Alzheimer's Disease : Peroxisome and Neurodegeneration.
Zarrouk A, Nury T, El Hajj HI, Gondcaille C, Andreoletti P, Moreau T, Cherkaoui-Malki M, Berger J, Hammami M, Lizard G, Vejux A. Zarrouk A, et al. Adv Exp Med Biol. 2020;1299:91-104. doi: 10.1007/978-3-030-60204-8_8. Adv Exp Med Biol. 2020. PMID: 33417210 Review.
Cited by
- Comparison of histological procedures and antigenicity of human post-mortem brains fixed with solutions used in gross anatomy laboratories.
Frigon EM, Gérin-Lajoie A, Dadar M, Boire D, Maranzano J. Frigon EM, et al. Front Neuroanat. 2024 Apr 10;18:1372953. doi: 10.3389/fnana.2024.1372953. eCollection 2024. Front Neuroanat. 2024. PMID: 38659652 Free PMC article. - The Azalea Hypothesis of Alzheimer Disease: A Functional Iron Deficiency Promotes Neurodegeneration.
LeVine SM. LeVine SM. Neuroscientist. 2024 Oct;30(5):525-544. doi: 10.1177/10738584231191743. Epub 2023 Aug 20. Neuroscientist. 2024. PMID: 37599439 Free PMC article. Review. - The role of iron metabolism in the pathogenesis and treatment of multiple sclerosis.
Duarte-Silva E, Meuth SG, Peixoto CA. Duarte-Silva E, et al. Front Immunol. 2023 Mar 17;14:1137635. doi: 10.3389/fimmu.2023.1137635. eCollection 2023. Front Immunol. 2023. PMID: 37006264 Free PMC article. Review. - Exploring Whether Iron Sequestration within the CNS of Patients with Alzheimer's Disease Causes a Functional Iron Deficiency That Advances Neurodegeneration.
LeVine SM, Tsau S, Gunewardena S. LeVine SM, et al. Brain Sci. 2023 Mar 18;13(3):511. doi: 10.3390/brainsci13030511. Brain Sci. 2023. PMID: 36979320 Free PMC article. - Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis.
Pietroboni AM, Colombi A, Contarino VE, Russo FML, Conte G, Morabito A, Siggillino S, Carandini T, Fenoglio C, Arighi A, De Riz MA, Arcaro M, Sacchi L, Fumagalli GG, Bianchi AM, Triulzi F, Scarpini E, Galimberti D. Pietroboni AM, et al. Eur Radiol. 2023 Aug;33(8):5368-5377. doi: 10.1007/s00330-022-09338-6. Epub 2022 Dec 23. Eur Radiol. 2023. PMID: 36562783
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical